Rising Drug Resistance Among Gram-Negative Pathogens in Bloodstream Infections: A Multicenter Study in Ulanhot, Inner Mongolia (2017-2021)
Medical Science Monitor · 2023
DOI: 10.12659/msm.940686 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Medical Science Monitor, 2023. Verfasst von Yinxia Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Xing'an League People's Hospital, Xing'an League, Ulanhot, Inner Mongolia, China (mainland). Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Bacteremia, Sepsis. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Xing'an League People's Hospital, Xing'an League, Ulanhot, Inner Mongolia, China (mainland).
- Department of Laboratory Medicine, Ulanhot People's Hospital, Xing'an League, Ulanhot, Inner Mongolia, China (mainland).
- Department of Laboratory Medicine, Keyou Qianqi People's Hospital, Xing'an League, Tongliao, Inner Mongolia, China (mainland).
Zitieren
APA
Feng, Y., Wang, Z., Hao, Z., Du, J., & Jiang, H. (2023). Rising Drug Resistance Among Gram-Negative Pathogens in Bloodstream Infections: A Multicenter Study in Ulanhot, Inner Mongolia (2017-2021). Medical Science Monitor. https://doi.org/10.12659/msm.940686
Vancouver
Feng Y, Wang Z, Hao Z, Du J, Jiang H. Rising Drug Resistance Among Gram-Negative Pathogens in Bloodstream Infections: A Multicenter Study in Ulanhot, Inner Mongolia (2017-2021). Medical Science Monitor. 2023. doi:10.12659/msm.940686
BibTeX
@article{Feng2023,
author = {Feng, Yinxia and Wang, Zhijun and Hao, Zelin and Du, Jinlong and Jiang, Hui},
title = {Rising Drug Resistance Among Gram-Negative Pathogens in Bloodstream Infections: A Multicenter Study in Ulanhot, Inner Mongolia (2017-2021)},
journal = {Medical Science Monitor},
year = {2023},
doi = {10.12659/msm.940686}
}
EUVIMED